PROC vs. GRFS, ONCSQ, QLI, LLY, NVO, JNJ, MRK, ABBV, AZN, and NVS Should you be buying Procaps Group stock or one of its competitors? The main competitors of Procaps Group include Grifols (GRFS), OncoSec Medical (ONCSQ), Qilian International Holding Group (QLI), Eli Lilly and Company (LLY), Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), and Novartis (NVS). These companies are all part of the "pharmaceutical preparations" industry.
Grifols (NASDAQ:GRFS ) and Procaps Group (NASDAQ:PROC ) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, community ranking, earnings, valuation and risk.
Procaps Group has a net margin of 12.61% compared to Procaps Group's net margin of 0.90%. Grifols' return on equity of 283.06% beat Procaps Group's return on equity.
In the previous week, Grifols had 2 more articles in the media than Procaps Group. MarketBeat recorded 3 mentions for Grifols and 1 mentions for Procaps Group. Grifols' average media sentiment score of 1.89 beat Procaps Group's score of 0.39 indicating that Procaps Group is being referred to more favorably in the news media.
Grifols has higher revenue and earnings than Procaps Group.
Grifols currently has a consensus target price of $10.50, indicating a potential upside of 46.65%. Procaps Group has a consensus target price of $4.50, indicating a potential upside of 63.04%. Given Grifols' stronger consensus rating and higher possible upside, analysts plainly believe Procaps Group is more favorable than Grifols.
Grifols has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.
Grifols received 345 more outperform votes than Procaps Group when rated by MarketBeat users. Likewise, 55.95% of users gave Grifols an outperform vote while only 37.50% of users gave Procaps Group an outperform vote.
Summary Grifols and Procaps Group tied by winning 6 of the 12 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding PROC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Procaps Group Competitors List
Related Companies and Tools
